Board Meeting11 May 2026, 03:10 pm
Aarti Pharmalabs Board Meeting on May 18, 2026
AI Summary
Aarti Pharmalabs Ltd has scheduled a Board of Directors meeting on May 18, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The board will also consider recommending a final dividend, if any, for the financial year ended March 31, 2026. The trading window, which has been closed since April 1, 2026, will remain closed until May 20, 2026.
Key Highlights
- Board meeting scheduled for May 18, 2026, to approve audited financial results.
- Consideration of final dividend for FY26 is on the agenda.
- Trading window remains closed until May 20, 2026.
Price Impact
More from AARTIPHARM